DiNuzzo Private Wealth’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02K Sell
13
-1
-7% -$68 ﹤0.01% 891
2026
Q1
$905 Hold
14
﹤0.01% 897
2025
Q4
$943 Sell
14
-2
-13% -$135 ﹤0.01% 891
2025
Q3
$1.17K Buy
16
+2
+14% +$133 ﹤0.01% 820
2025
Q2
$729 Sell
14
-1
-7% -$57 ﹤0.01% 961
2025
Q1
$958 Buy
15
+2
+15% +$116 ﹤0.01% 842
2024
Q4
$622 Hold
13
﹤0.01% 1006
2024
Q3
$745 Sell
13
-1
-7% -$57 ﹤0.01% 968
2024
Q2
$734 Buy
14
+4
+40% +$175 ﹤0.01% 914
2024
Q1
$407 Sell
10
-2
-17% -$75 ﹤0.01% 1039
2023
Q4
$444 Buy
+12
New +$452 ﹤0.01% 1024

Other funds holding HALO

DiNuzzo Private Wealth's HALO Position: Q2 2026 in Review

DiNuzzo Private Wealth reduced its Halozyme (HALO) stake by 7.1% in Q2 2026, selling an estimated $68 and leaving 13 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

DiNuzzo Private Wealth first reported a position in HALO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.17K in Q3 2025. 207 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • DiNuzzo Private Wealth held 13 shares of Halozyme worth $1.02K as of Q2 2026.
  • DiNuzzo Private Wealth sold 1 Halozyme share in Q2 2026, an estimated $68.
  • Halozyme made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #891 holding.
  • DiNuzzo Private Wealth first reported a position in Halozyme in Q4 2023 and has held it in 11 quarters since.
  • DiNuzzo Private Wealth's Halozyme position peaked at $1.17K in Q3 2025.
  • 207 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.